Synthetic Naphthoquinone Derivatives as Anticancer Agents in Ovarian Cancer: Cytotoxicity Assay and Investigation of Possible Biological Mechanisms Action

Chem Biodivers. 2023 Feb;20(2):e202200807. doi: 10.1002/cbdv.202200807. Epub 2023 Jan 11.

Abstract

In this study, eight naphthoquinone derivatives were synthesized in yields ranging from 52 to 96% using easy, fast, and low-cost methodologies. All naphthoquinone derivatives were screened for their in vitro anti-proliferative activities against OVCA A2780 cancer cell lines. Amongst all analysed compounds, derivatives 3-5 presented the most prominent cytotoxic potential. Naphthoquinones 3 and 4, bearing sulfur-containing groups, were identified as having high potential for ROS production, in particular the superoxide anion. Furthermore, 3 and 4 compounds caused a decrease in the cell population in G0/G1 and induced more than 90% of the cell population to apoptosis. Compound 5 did not act in any of these processes. Finally, compounds 3-5 were tested for their inhibitory ability against PI3K and MAPK. Compounds 3 and 4 do not inhibit the PI3K enzyme. On the other hand, the naphthoquinone-polyphenol 5 was only able to inhibit the percentage of cells expressing pERK.

Keywords: anticancer activity; naphthoquinone; ovarian cancer.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Humans
  • Naphthoquinones* / pharmacology
  • Ovarian Neoplasms*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Structure-Activity Relationship

Substances

  • Naphthoquinones
  • Antineoplastic Agents
  • Phosphatidylinositol 3-Kinases